NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-11-04 11:15இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Deepak Nitrite Reports Record Q2 FY27 Revenue of ₹3,091 Cr, Up 61% YoY; Files Concall Transcript
Deepak Nitrite has submitted the transcript of its Q2 & H1 FY27 earnings conference call held on October 30, 2026. The company reported record consolidated revenue from operations of ₹3,091 crore for Q2 FY27, up 19% QoQ and 61% YoY, driven primarily by strong performance in the Phenolics segment. Toward the end of the quarter, Deepak Chemtech commissioned chlorination and specialty chemical assets in Dahej with a capex of approximately ₹300 crore. Additionally, progress continues on its integrated Polycarbonate project, including relocation and dismantling activities in Germany.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite published the official transcript of its Q2 & H1 FY27 earnings conference call.
ஏன் இது முக்கியம்Provides granular operational details on the record quarterly performance, newly commissioned specialty assets, and progress on major capex programs.
📅 குறுகிய காலம்Market reactions typically reflect the headline earnings already disclosed; the transcript clarifies near-term operational trends in Advanced Intermediates and Phenolics.
📈 நீண்ட காலம்Vertical integration from ammonia to amines and propylene to polycarbonate, alongside downstream solvents (MIBK/MIBC), is structurally expanding higher-margin specialty chemical exposure.
⚠ அபாய எச்சரிக்கைகள்
Global oversupply and pricing pressure from Chinese chemical producers
Execution and relocation risks associated with the Germany-to-India polycarbonate plant
👀 கவனிக்க வேண்டியவை
Track the commercial ramp-up and margin contributions from the newly commissioned ₹300 crore chlorination facility, along with execution timelines on the Polycarbonate project.
Deepak Nitrite Reports Highest-Ever Q2 FY27 PAT of ₹398 Cr (+235% YoY); Revenue Up 61% to ₹3,091 Cr
Deepak Nitrite delivered record financial results for Q2 FY27, with consolidated revenue rising 61% YoY to ₹3,091 crore and PAT surging 235% YoY to ₹398 crore. Growth was primarily driven by the Phenolics segment, where quarterly revenue surged 72% YoY to ₹2,291 crore and EBIT jumped 256% YoY to ₹515 crore due to favorable domestic spreads and import disruptions. The Advanced Intermediates segment saw a 38% YoY revenue increase to ₹811 crore, although margins faced global pricing pressure. Consolidated EBITDA margins expanded significantly to 20.8% in Q2 FY27 from 11.6% in Q2 FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite released its Q2 & H1 FY27 investor presentation showcasing record quarterly revenue of ₹3,091 crore and record net profit of ₹398 crore.
ஏன் இது முக்கியம்A sharp rebound in domestic phenolics realization and volumes has dramatically expanded consolidated EBITDA margins from 11.6% to 20.8%, reversing previous margin headwinds from Asian dumping.
📅 குறுகிய காலம்Positive sentiment driven by record-high quarterly revenue and profit that significantly beat recent run-rates.
📈 நீண்ட காலம்Integration across the Cumene-Phenol-Acetone chain toward Polycarbonate and downstream chemicals (MIBK/MIBC) provides structural protection against global dumping cycles.
⚠ அபாய எச்சரிக்கைகள்
Margin volatility in Advanced Intermediates due to aggressive global pricing and dumping
High dependence on Phenolics segment for overall company profitability
Potential normalization of import disruptions reducing domestic realization premiums
👀 கவனிக்க வேண்டியவை
Track whether high Phenolics spreads and domestic import substitution advantages sustain over coming quarters, alongside execution updates on the downstream Polycarbonate, MIBK, and MIBC projects.
Deepak Nitrite has submitted its standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The meeting commenced at 2:00 PM and concluded at 4:00 PM on October 29, 2026, accompanied by a Limited Review Report from statutory auditors Deloitte Haskins & Sells LLP. Detailed financial figures were not reproduced in the covering transmission letter. Investors will need to refer to the full financial tables to assess performance relative to TTM revenue of Rs 8,575 Cr and recent Q1 FY27 revenue of Rs 2,577.6 Cr.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite's board has officially considered and approved the un-audited financial results for Q2 and H1 ended September 30, 2026.
ஏன் இது முக்கியம்Provides quarterly financial performance indicators against previous quarters, showing whether the top-line momentum from Q1 FY27 is sustained amidst industry-wide pricing headwinds.
Meeting duration: 2:00 P.M. to 4:00 P.M.Financial period ended: 30th செப்டம்பர், 2026
📅 குறுகிய காலம்Market focus will shift to the underlying numbers (EBITDA margin, net profit growth) once the complete quarterly disclosure is parsed.
📈 நீண்ட காலம்Long-term outlook remains dependent on the commissioning and ramp-up of downstream MIBK, MIBC, and the integrated Polycarbonate project to counter Chinese supply dumping.
⚠ அபாய எச்சரிக்கைகள்
Full numerical tables omitted in the covering document text
Pricing pressures from global supply buildup in Phenolics
👀 கவனிக்க வேண்டியவை
Track the detailed standalone and consolidated financial statements and management commentary regarding margin performance in the Phenolics segment and updates on the Polycarbonate expansion.
Deepak Nitrite's wholly owned subsidiary, Deepak Chem Tech Limited, has commissioned manufacturing operations of its Chlorination and Specialty chemical plant along with utilities and infrastructure on September 29, 2026, at Dahej, Gujarat. The total capital expenditure incurred for this project is approximately Rs 300 crore as of the commencement date. This capex represents ~9.3% of the company's net worth (Rs 3,215 crore) and ~3.5% of TTM revenue (Rs 8,575 crore). The facility aligns with the group's strategy to deepen vertical integration into downstream specialty chemicals.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Chem Tech Limited commenced commercial manufacturing at its chlorination and specialty chemical plant at Dahej.
ஏன் இது முக்கியம்Adds higher-margin specialty chemical manufacturing capability, expanding downstream integration and supporting future earnings growth.
Total capex incurred: Rs 300 CroresCapex to Net Worth: ~9.3%Capex to TTM Revenue: ~3.5%Commissioning date: 29th செப்டம்பர் 2026
📅 குறுகிய காலம்Positive sentiment from successful project commissioning without reported delays, though near-term earnings impact depends on ramp-up speed.
📈 நீண்ட காலம்Enhances the company's vertical integration and expands the portfolio of higher-value specialty chemicals, mitigating commodity exposure.
⚠ அபாய எச்சரிக்கைகள்
Plant ramp-up delays or initial operational bottlenecks
Exposure to pricing volatility and global demand fluctuations in downstream chemicals
👀 கவனிக்க வேண்டியவை
Track the ramp-up schedule and capacity utilization figures in upcoming quarterly updates to gauge revenue and margin contribution from the new specialty facility.
Deepak Nitrite and DPL Infuse ₹175 Cr in Subsidiary Deepak Chem Tech via 9% OCRPS
Deepak Nitrite Limited (DNL) and its wholly owned subsidiary Deepak Phenolics Limited (DPL) have infused a total of ₹175 Crore into Deepak Chem Tech Limited (DCTL) via 9% Optionally Convertible Redeemable Preference Shares (OCRPS). DNL subscribed to 80 lakh shares (₹80 Crore) while DPL subscribed to 95 lakh shares (₹95 Crore) at ₹100 par value. The capital will support DCTL's ongoing project expenses and general corporate purposes across its chemical plants in Gujarat. DCTL has scaled its turnover rapidly from ₹0.86 Crore in FY24 to ₹172.23 Crore in FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுDNL and DPL completed an internal capital infusion of ₹175 Crore into wholly owned subsidiary DCTL via 9% OCRPS.
ஏன் இது முக்கியம்Provides necessary funding to scale DCTL's specialty downstream projects without increasing consolidated external debt.
Total Infusion Amount: ₹175 CroresDNL Direct Infusion: ₹80 CroresDPL Infusion: ₹95 CroresDCTL FY26 Turnover: ₹172.23 CroresInfusion vs TTM Revenue: ~2.0%
📅 குறுகிய காலம்Neutral; this is an internal group restructuring/funding event with no immediate impact on consolidated quarterly earnings.
📈 நீண்ட காலம்Supports DNL's strategic vertical integration into advanced intermediates and downstream chemistries to diversify away from commodity cycles.
⚠ அபாய எச்சரிக்கைகள்
Project execution timelines and ramp-up risks at DCTL's Gujarat manufacturing sites.
👀 கவனிக்க வேண்டியவை
Track the commercialization and revenue ramp-up of DCTL's fluorination, nitric acid, nitration, and hydrogenation projects in upcoming quarterly updates.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
₹2,592 Cr Revenue: Deepak Nitrite Reports Record Q1 FY27 Performance and New Project Commissioning
Deepak Nitrite reported a record-breaking Q1 FY27 with consolidated revenue of ₹2,592 crore, a 35% YoY increase. EBITDA margins expanded significantly to 21% from 11% a year ago, leading to a 207% YoY surge in PAT to ₹345 crore. The company is successfully transitioning into an integrated nitrogen platform, with the ammonia-to-amines integration complete. Management confirmed that MIBK, MIBC, and Acetophenone projects are scheduled for commissioning in August 2026, which will further deepen downstream integration.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite has transitioned from a nitration-focused company to an integrated nitrogen platform and is now moving into high-value downstream products like MIBK and MIBC.
ஏன் இது முக்கியம்The shift towards downstream integration and the upcoming Polycarbonate project reduces reliance on commodity chemical cycles and improves structural cost competitiveness against global imports.
Q1 FY27 Revenue: ₹2,592 கோடிQ1 PAT vs TTM PAT: 62.6%EBITDA லாப வரம்பு: 21%Phenolics EBIT Growth (YoY): 254%Advanced Intermediates Revenue: ₹804 கோடி
📅 குறுகிய காலம்The stock is likely to react positively to the record earnings and the immediate catalyst of new plant commissionings in August 2026.
📈 நீண்ட காலம்The company's strategy to build an integrated advanced material platform, including India's first integrated Polycarbonate project, positions it for structural growth and margin resilience over the next 3-5 years.
⚠ அபாய எச்சரிக்கைகள்
Global oversupply and dumping by Asian producers
Volatility in feedstock prices (Propylene and Benzene)
Execution risk for large-scale greenfield projects
👀 கவனிக்க வேண்டியவை
Investors should monitor the successful ramp-up of the MIBK and MIBC plants in Q2 FY27 and track the execution milestones of the large-scale Polycarbonate project. The sustainability of the 21% EBITDA margin amidst global chemical price volatility is a key metric to watch in upcoming quarters.
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited, has commissioned its Methyl Isobutyl Ketone (MIBK) and Methyl Isobutyl Carbinol (MIBC) plant at Dahej, Gujarat. The project involved a capital expenditure of approximately ₹735 Crores, which represents about 22.8% of the company's current net worth (₹3,215 Cr). This commissioning marks a significant move into downstream specialty chemicals, aiming to diversify the product mix and improve margin resilience against global dumping. The plant includes necessary offsite utilities and infrastructure, transitioning the project from the investment phase to the revenue-generation phase.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully completed and commissioned a major ₹735 Cr downstream expansion project, moving from construction to production.
ஏன் இது முக்கியம்This expansion into MIBK and MIBC reduces reliance on commodity chemicals and provides a hedge against global dumping by moving further down the value chain into specialty applications.
Project Capex: ₹735 CroresCapex vs Net Worth: ~22.8%Capex vs TTM Revenue: ~9.3%Commissioning Date: ஆகஸ்ட் 6, 2026
📅 குறுகிய காலம்Positive sentiment is expected as the project begins contributing to the top line, potentially improving the revenue run rate from Q3 FY27 onwards.
📈 நீண்ட காலம்Structurally significant as it strengthens the company's 'China+1' positioning and vertical integration, creating higher entry barriers in the specialty chemicals segment.
👀 கவனிக்க வேண்டியவை
Monitor the capacity utilization ramp-up and the resulting impact on consolidated operating margins (OPM) in the next 2-3 quarters. Investors should also watch for management commentary regarding domestic market share gains against imported MIBK/MIBC.
Deepak Nitrite Approves ₹7.50 Dividend and Key Leadership Elevations at 55th AGM
Deepak Nitrite concluded its 55th Annual General Meeting on August 5, 2026, where shareholders approved a dividend of ₹7.50 per share (375% of face value) for FY26. The meeting formalized significant leadership transitions, including the elevation of Mautik Mehta and Meghav Mehta to Deputy Managing Directors for 5-year terms. Additionally, Anant Pande was appointed as Executive Director & CMO, and Sanjay Upadhyay was re-appointed as Group CFO for another 5 years. These moves solidify the management structure as the company pursues its integrated Polycarbonate and downstream chemical projects.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned its leadership team with new Deputy MD roles and a dedicated CMO, while confirming the FY26 dividend payout.
ஏன் இது முக்கியம்Management continuity and a clear leadership hierarchy are critical as the company manages a ₹23,720 Cr market cap and navigates global oversupply challenges in the chemical sector.
Dividend per share: ₹7.50Dividend % of Face Value: 375%Deputy MD Appointment Term: 5 yearsEstimated Dividend Payout: ~₹102 கோடிDividend vs TTM PAT: ~18.5%
📅 குறுகிய காலம்The stock is likely to react neutrally as the AGM proceedings and dividend were largely anticipated by the market.
📈 நீண்ட காலம்The 5-year mandates for the Deputy MDs and CFO provide structural stability for the company's long-term shift toward high-margin downstream products.
⚠ அபாய எச்சரிக்கைகள்
Promoter remuneration levels (Special Resolution)
Global oversupply impacting domestic margins
👀 கவனிக்க வேண்டியவை
Investors should monitor the final voting results to check for any significant dissent on promoter remuneration (Resolution 13). The focus remains on the execution timeline of the upcoming Polycarbonate and MIBK/MIBC projects mentioned in the company's growth strategy.
207% PAT Growth: Deepak Nitrite Reports Highest-Ever Quarterly Performance in Q1 FY27
Deepak Nitrite delivered a record-breaking Q1 FY27, with consolidated revenue growing 35% YoY to 2,592 Cr. Profitability saw a massive surge as PAT rose 207% YoY to 345 Cr, driven by a 254% EBIT jump in the Phenolics segment. The company is aggressively pursuing its 2,900 Cr Polycarbonate project, with equipment shipments from Germany already arriving at the Dahej site. EBITDA margins expanded significantly to 21.4% from 11.2% in the year-ago period, reflecting strong operational leverage.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has achieved a significant margin breakout, with EBITDA growing 159% YoY, moving past the margin compression seen in FY26.
ஏன் இது முக்கியம்The record performance validates the company's vertical integration strategy and its ability to maintain high operating rates (Phenolics) despite global chemical industry volatility.
📅 குறுகிய காலம்The stock is likely to react positively to the substantial earnings beat and the 'highest-ever' quarterly performance milestone.
📈 நீண்ட காலம்Structural growth is underpinned by the 2,900 Cr downstream expansion into Polycarbonates, which aims to substitute imports and deepen the value chain.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical tensions affecting logistics costs
Pricing uncertainty in chemical intermediates
Execution risk for the large-scale Polycarbonate project
👀 கவனிக்க வேண்டியவை
Watch for the execution timeline of the 165,000 MT/yr Polycarbonate plant and the impact of the 15-year Petronet LNG agreement on long-term feedstock cost stability.
Rs 2,500 Cr Investment: Deepak Nitrite to Set Up 240 KTA Bisphenol A Plant
Deepak Nitrite's subsidiary, Deepak Chem Tech Limited (DCTL), has approved a major investment of approximately Rs 2,500 crore to establish a Bisphenol A (BPA) manufacturing plant. The project features a capacity of up to 240 KTA and includes greenfield infrastructure. This investment is highly significant, representing roughly 31.7% of the company's TTM revenue and 77.8% of its current net worth. The move completes a strategic value chain from Phenol/Acetone to Polycarbonate, aiming to capture growth in the Indian Epoxy resin market and captive requirements.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite has formally committed to a large-scale downstream expansion into Bisphenol A, moving beyond its existing Phenolics business.
ஏன் இது முக்கியம்This project creates a highly integrated chemical platform, reducing raw material risks for their upcoming Polycarbonate plant and entering the high-demand Epoxy resin market, which currently relies on imports.
Project Investment: Rs 2,500 கோடிCapacity: 240 KTAInvestment vs TTM Revenue: ~31.7%Investment vs Net Worth: ~77.8%Current Debt: Rs 60 கோடி
📅 குறுகிய காலம்The market is likely to react positively to the scale of the expansion and the strategic move towards higher-value integrated products.
📈 நீண்ட காலம்If executed successfully, this transforms Deepak Nitrite into a dominant integrated player in the BPA-Polycarbonate chain, potentially improving long-term margins and market share.
⚠ அபாய எச்சரிக்கைகள்
Execution risk of a large-scale greenfield project
👀 கவனிக்க வேண்டியவை
Watch for the finalization of detailed engineering and the specific debt-equity funding mix, as this will significantly alter the company's leverage profile from its current near-debt-free status.
Deepak Nitrite Appoints Lohit Shringi as CEO for Advanced Intermediates Business
Deepak Nitrite has appointed Shri Lohit Shringi as the Chief Executive Officer for its Advanced Intermediates (AI) business, effective August 4, 2026. Shringi brings over 27 years of experience, having previously served as Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited. This leadership addition is strategic as the AI segment is currently undergoing both brownfield and greenfield expansions to deepen vertical integration. Given the company's TTM revenue of ‡7,887 Cr and current margin pressures from global dumping, this appointment aims to strengthen P&L management in a core growth area.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned the leadership of its Advanced Intermediates business to a dedicated CEO with extensive specialty chemicals experience.
ஏன் இது முக்கியம்The Advanced Intermediates segment is central to Deepak Nitrite's 'China+1' strategy and downstream integration; professional leadership is vital to navigate current global oversupply and pricing challenges.
📅 குறுகிய காலம்The market is likely to view the addition of a seasoned industry veteran from PCBL and DuPont as a positive step for operational stability.
📈 நீண்ட காலம்Shringi's experience in specialty chemicals and global markets is structurally significant for the company's move into high-value downstream products like MIBK and Polycarbonates.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in ongoing greenfield projects
Global oversupply impacting AI segment margins
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the AI segment's expansion projects and margin recovery in upcoming quarterly results under the new leadership.
₹120 Cr Investment in Deepak Chem Tech by Deepak Phenolics for Project Funding
Deepak Nitrite's subsidiary, Deepak Phenolics Limited (DPL), has invested ₹120 crore in another wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL). The investment is made through 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to support DCTL's project expenses and strengthen its capital base. DCTL is scaling rapidly, with its turnover increasing from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation supports the group's expansion into specialized segments like Fluorination and Nitric Acid.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite has moved ₹120 crore of capital from its Phenolics subsidiary to its Chem Tech subsidiary to fund ongoing specialized chemical projects.
ஏன் இது முக்கியம்This demonstrates the company's strategy of using cash flows from its established Phenolics business to fund high-growth, downstream specialized chemical segments without external debt.
Investment Amount: ₹120.00 CroresDCTL FY26 Turnover: ₹172.23 CroresInvestment vs Net Worth: ~3.7%OCRPS Coupon Rate: 9%DCTL FY25 Turnover: ₹9.43 Crores
📅 குறுகிய காலம்Neutral, as this is an intra-group transaction with no immediate impact on consolidated financial performance.
📈 நீண்ட காலம்Positive, as it facilitates the expansion of DCTL's specialized chemical portfolio, which is central to the company's long-term 'China+1' and import substitution strategy.
⚠ அபாய எச்சரிக்கைகள்
Execution risk of ongoing projects within DCTL
Cyclicality and global dumping risks in the chemical sector
👀 கவனிக்க வேண்டியவை
Investors should monitor the operational ramp-up and margin profile of Deepak Chem Tech (DCTL) as it transitions from a project-phase entity to a meaningful revenue contributor.
$78.43 Million Corporate Guarantee Issued for Oman Subsidiary
Deepak Nitrite Limited has executed a Deed of Guarantee for US $78.43 million (approximately ₹655 crore) in favor of Bank Muscat SAOG. This guarantee secures a term loan for its 51% subsidiary, Deepak Oman Industries (SFZ) LLC (DOIL). The remaining 49% of DOIL is held by promoter entities, and the company will charge a guarantee commission for this service. This commitment represents a significant contingent liability, equivalent to approximately 20.4% of the company's current net worth.
உச்சம் நம்பிக்கை
என்ன மாறியதுDeepak Nitrite has formally committed to backing a $78.43M loan for its Oman-based subsidiary, creating a new contingent liability.
ஏன் இது முக்கியம்This move facilitates capital for the company's international expansion in Oman but links the parent company's balance sheet to the subsidiary's financial performance.
Guarantee Amount: US $78.43 MillionSubsidiary Ownership: 51%Guarantee vs Net Worth: ~20.4%Guarantee vs TTM Revenue: ~8.3%Parent Net Worth: ₹3,215 கோடி
📅 குறுகிய காலம்The market is likely to view this as a routine support for a subsidiary, though the size of the contingent liability may be noted by analysts.
📈 நீண்ட காலம்The structural impact depends on the successful execution and profitability of the Oman project; failure there could impact the parent's credit profile.
⚠ அபாய எச்சரிக்கைகள்
Contingent liability risk
Related-party involvement (Promoters hold 49% of the subsidiary)
👀 கவனிக்க வேண்டியவை
Investors should monitor the operational progress and debt-servicing capability of the Oman subsidiary to ensure the guarantee is not invoked.
Deepak Nitrite Subsidiary DCTL Raises ₹120 Crore from Deepak Phenolics via OCRPS
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite, has allotted 1.2 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to Deepak Phenolics Limited (DPL), another wholly-owned subsidiary. The transaction, valued at ₹120 crore, is aimed at strengthening DCTL's capital base and funding its ongoing project expenses. DCTL is currently scaling its operations in Fluorination and Nitration, with its turnover jumping significantly from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation allows the group to utilize surplus funds from DPL to fuel growth in DCTL.
முக்கிய அம்சங்கள்
DCTL allotted 1,20,00,000 9% OCRPS at a face value of ₹100 each, totaling ₹120 crore.The investment was made by Deepak Phenolics Limited (DPL), a fellow wholly-owned subsidiary of Deepak Nitrite.DCTL's turnover showed exponential growth, reaching ₹172.23 crore in FY 2025-26 compared to just ₹9.43 crore in FY 2024-25.Funds will be utilized for project expenses across Fluorination, Nitric Acid, Nitration, and Hydrogenation plants in Gujarat.The transaction was conducted at arm's length and does not change the parent company's 100% control over the subsidiaries.
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine internal capital management move; however, the rapid turnover growth in DCTL suggests that the subsidiary's new projects are gaining traction and should be monitored for future consolidated earnings impact.
Deepak Nitrite Q4 FY26 PAT Surges 120% QoQ to ₹220 Cr; ₹7.5 Dividend Recommended
Deepak Nitrite reported a strong sequential recovery in Q4 FY26, with consolidated PAT rising 120% QoQ to ₹220 crore and EBITDA margins expanding significantly to 18% from 11% in Q3. The Phenolics segment was a major driver, achieving 20% EBIT margins despite global supply chain disruptions in the Middle East. For the full year FY26, the company recorded revenues of ₹7,947 crore and a PAT of ₹551 crore. Management confirmed that strategic projects including MIBK, MIBC, and the polycarbonate facility are on track, with some commissioning expected in Q2 FY27.
முக்கிய அம்சங்கள்
Q4 FY26 EBITDA grew 74% sequentially to ₹383 crore, with margins improving to 18% from 11% in Q3.Phenolics segment EBIT margins reached 20% in Q4, supported by stable plant operations and improving spreads.Advanced Intermediates revenue grew 8% YoY to ₹708 crore, driven by stable domestic demand in India.The Board recommended a final dividend of ₹7.5 per equity share for FY26.Strategic MIBK and MIBC projects are scheduled for commissioning in Q2 FY27, enhancing future growth visibility.
👀 கவனிக்க வேண்டியவை
Investors should view the sharp sequential margin recovery as a positive sign of operational resilience. Monitor the timely commissioning of the MIBK and MIBC projects in Q2 FY27 as they are expected to further diversify the value-added product portfolio.
Deepak Nitrite Q4 FY26 PAT Jumps 120% Q-o-Q to ₹220 Cr; EBITDA Up 74% Sequentially
Deepak Nitrite reported a strong sequential recovery in Q4 FY26, with PAT rising 120% Q-o-Q to ₹220 crore and EBITDA growing 74% to ₹383 crore. While the full-year FY26 performance saw a 21% decline in PAT to ₹551 crore due to global pricing pressures, the quarterly momentum indicates a sharp turnaround in margins. The Phenolics segment delivered robust performance with a 97% Q-o-Q EBIT growth, supported by record production volumes. The company is also making significant progress on its Polycarbonate project and has established a new ₹100 crore R&D center to drive future growth.
முக்கிய அம்சங்கள்
Q4 FY26 EBITDA grew 74% Q-o-Q to ₹383 crore, driven by proactive procurement and backward integration benefits.Phenolics segment EBIT rose 97% Q-o-Q to ₹287 crore, achieving highest-ever production and sales in FY26.Advanced Intermediates segment EBIT surged 125% Q-o-Q to ₹34 crore, aided by a favorable product mix.Polycarbonate project on track with equipment shipments from Germany and a long-term HyCO plant agreement with Linde.Maintained a strong dividend payout of 375% for FY26, including special and final dividends.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant sequential margin expansion and the company's successful navigation of global supply chain disruptions. The progress on the Polycarbonate project and the new R&D facility strengthen the long-term growth thesis for this chemical major.
Deepak Nitrite Appoints Anant Pande as ED & CMO; Re-appoints Girish Satarkar for 3 Years
Deepak Nitrite has announced a significant leadership transition with the appointment of Shri Anant Pande as Executive Director and Chief Manufacturing Officer for a three-year term starting August 5, 2026. Mr. Pande brings 40 years of extensive experience from leadership roles at Jubilant Life Sciences and Atul Limited. Concurrently, the board has approved the re-appointment of Shri Girish Satarkar as Executive Director for another three-year term. These changes come as Shri Ajay C. Mehta prepares to retire from the board at the upcoming Annual General Meeting.
முக்கிய அம்சங்கள்
Shri Anant Pande appointed as Executive Director & Chief Manufacturing Officer for a 3-year term starting August 5, 2026Shri Girish Satarkar re-appointed as Executive Director for a 3-year term effective August 4, 2026Shri Ajay C. Mehta to retire from the Board at the ensuing AGM after not seeking re-appointmentNew appointee Anant Pande has 40 years of experience in life sciences, chemicals, and pharmaceuticalsGirish Satarkar brings over 37 years of chemical industry experience to his continued role
👀 கவனிக்க வேண்டியவை
This is a routine succession and leadership strengthening move. Investors should monitor if the new Chief Manufacturing Officer introduces any operational efficiencies in the upcoming quarters.
Deepak Nitrite Recommends Final Dividend of ₹7.50 Per Share (375%) for FY2026
The Board of Directors of Deepak Nitrite Limited has recommended a final dividend of ₹7.50 per equity share for the financial year ended March 31, 2026. This represents a significant 375% payout on the face value of ₹2 per share. The dividend is applicable to over 13.63 crore equity shares and is subject to shareholder approval at the upcoming 55th Annual General Meeting. Upon approval, the payment will be processed within 30 days of the AGM date.
முக்கிய அம்சங்கள்
Recommended final dividend of ₹7.50 per equity share for the year ended March 31, 2026Dividend payout represents 375% of the face value of ₹2 per shareTotal number of equity shares eligible for dividend stands at 13,63,93,041Payment to be completed within 30 days from the date of the 55th Annual General Meeting
👀 கவனிக்க வேண்டியவை
Investors should monitor the announcement of the record date to ensure eligibility for the dividend. The healthy payout reflects the company's strong cash position and commitment to shareholder returns.
Deepak Nitrite Q4 FY26 Net Profit Jumps 103% YoY to ₹202.5 Cr Despite Annual Revenue Dip
Deepak Nitrite reported a strong recovery in Q4 FY26 with consolidated net profit doubling to ₹202.50 crore compared to ₹99.82 crore in the same quarter last year. For the full year FY26, consolidated revenue stood at ₹7,887.07 crore, a 4.8% decline from ₹8,281.93 crore in FY25, primarily due to lower realizations in the Phenolics segment. Annual net profit for FY26 settled at ₹610.21 crore, down from ₹697.37 crore in the previous year. Despite the annual decline, the sharp quarterly growth indicates significant margin improvement and operational recovery in the latter half of the year.
முக்கிய அம்சங்கள்
Q4 FY26 Consolidated Net Profit surged 102.8% YoY to ₹202.50 crore.Full-year FY26 Consolidated Revenue from operations stood at ₹7,887.07 crore vs ₹8,281.93 crore in FY25.Phenolics segment revenue for FY26 decreased to ₹5,400.68 crore from ₹5,805.10 crore YoY.Advanced Intermediates segment revenue remained resilient at ₹2,553.32 crore for FY26.Consolidated Total Assets grew to ₹8,680.68 crore as of March 31, 2026, from ₹7,717.57 crore in the previous year.
👀 கவனிக்க வேண்டியவை
Investors should view the strong Q4 performance as a sign of cyclical recovery and margin expansion. While annual figures are lower, the sequential and YoY quarterly growth suggests the company is navigating pricing pressures effectively.
Deepak Nitrite Elevates Maulik Mehta to Deputy Managing Director for 5-Year Term
Deepak Nitrite has announced the elevation of Shri Maulik Mehta to the position of Deputy Managing Director, effective May 9, 2026. This appointment follows the completion of his tenure as Executive Director & CEO on May 8, 2026, and is set for a period of five years. Shri Mehta, who has 18 years of experience and an executive MBA from Harvard, is the son of the current Chairman and Managing Director, Deepak C. Mehta. The move is intended to ensure leadership continuity and drive the company's long-term 'Responsible Chemistry' and 'Depend on Deepak' strategic initiatives.
முக்கிய அம்சங்கள்
Shri Maulik Mehta appointed as Deputy Managing Director for a 5-year term starting May 9, 2026Mehta brings 18 years of experience in business development, product development, and ESG initiativesEducational background includes an executive MBA from Harvard Business School and a Master's from Columbia UniversityThe appointee is the son of Chairman Deepak C. Mehta, signaling clear succession planning and promoter commitmentAppointment is subject to the approval of the company's shareholders
👀 கவனிக்க வேண்டியவை
Investors should view this elevation as a sign of leadership stability and planned succession within the promoter family. No immediate portfolio changes are necessary as the transition appears seamless and maintains strategic continuity.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
